drugset / Trial / NCT03956212
Inflammatory Mediators in Erythema Migrans
Completed
150 enrolled
University Medical Centre Ljubljana
University of Ljubljana School of Medicine, Slovenia · collab
NaSingle-groupOpen-labelBasic science
Summary
The main objective of this study is to characterize the inflammatory proteins, gene polymorphisms, and transcriptome profiles in patients with erythema migrans to gain better insight into pathogenesis of early Lyme borreliosis and to define new immune modulators that could serve as biomarkers of disease activity.
Timeline
- Start
- 2017-06-01
- Primary completion
- 2019-12-31
- Completion
- 2020-10-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Doxycycline | Small molecule | 100 mg | Oral |
Indications
No indication recorded.